Literature DB >> 24965824

Rituximab for childhood-onset nephrotic syndrome.

Elisabeth M Hodson1, Jonathan C Craig2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24965824     DOI： 10.1016/S0140-6736(14)60654-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  How randomised trials have improved the care of children with kidney disease.

Authors:  Elisabeth M Hodson; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2016-08-03       Impact factor: 3.714

2.  Childhood onset steroid-sensitive nephrotic syndrome continues into adulthood.

Authors:  Trine Korsgaard; René Frydensbjerg Andersen; Shivani Joshi; Søren Hagstrøm; Søren Rittig
Journal:  Pediatr Nephrol       Date:  2018-11-13       Impact factor: 3.714

3.  B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.

Authors:  Manuela Colucci; Rita Carsetti; Simona Cascioli; Federica Casiraghi; Annalisa Perna; Lucilla Ravà; Barbara Ruggiero; Francesco Emma; Marina Vivarelli
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

Review 4.  Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020.

Authors:  Rasmus Ehren; Marcus R Benz; Paul T Brinkkötter; Jörg Dötsch; Wolfgang R Eberl; Jutta Gellermann; Peter F Hoyer; Isabelle Jordans; Clemens Kamrath; Markus J Kemper; Kay Latta; Dominik Müller; Jun Oh; Burkhard Tönshoff; Stefanie Weber; Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2021-06-06       Impact factor: 3.714
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.